Literature DB >> 12015121

Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation.

Magdalena Kovacsovics1, Fabio Martinon, Olivier Micheau, Jean Luc Bodmer, Kay Hofmann, Jürg Tschopp.   

Abstract

Apoptotic cell death is characterized by several morphological nuclear changes, such as chromatin condensation and extensive fragmentation of chromosomal DNA. These alterations are primarily triggered through the activation of caspases, which subsequently cleave nuclear substrates. Caspase-3 induces processing of Acinus, which leads to chromatin condensation. DNA fragmentation is dependent on the DNase CAD, which is released from its inhibitor, ICAD, upon cleavage by caspase-3. DNA degradation is also induced by AIF and endonuclease G, which are both released from mitochondria upon death stimuli but do not require prior processing by caspases for their DNase activity. Here we report the identification of a widely expressed helicase designated Helicard, which contains two N-terminal CARD domains and a C-terminal helicase domain. Upon apoptotic stimuli, Helicard is cleaved by caspases, thereby separating the CARD domains from the helicase domain. While Helicard localizes in the cytoplasm, the helicase-containing fragment is found in the nucleus. Helicard accelerates Fas ligand-mediated DNA degradation, whereas a noncleavable or a helicase-dead Helicard mutant does not, implicating Helicard in the nuclear remodeling occurring during apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12015121     DOI: 10.1016/s0960-9822(02)00842-4

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  45 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  Satoshi Uematsu; Shizuo Akira
Journal:  J Mol Med (Berl)       Date:  2006-09       Impact factor: 4.599

Review 2.  The response of mammalian cells to double-stranded RNA.

Authors:  Michael P Gantier; Bryan R G Williams
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-14       Impact factor: 7.638

3.  Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2.

Authors:  Darja Bamming; Curt M Horvath
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

Review 4.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

5.  Cleavage of IPS-1 in cells infected with human rhinovirus.

Authors:  Jennifer Drahos; Vincent R Racaniello
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

Review 6.  Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.

Authors:  Paola M Barral; Devanand Sarkar; Zao-zhong Su; Glen N Barber; Rob DeSalle; Vincent R Racaniello; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2009-07-15       Impact factor: 12.310

Review 7.  dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity.

Authors:  Yaming Wang; Melissa Swiecki; Stephen A McCartney; Marco Colonna
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

8.  Junin virus infects mouse cells and induces innate immune responses.

Authors:  Christian D Cuevas; Madakasira Lavanya; Enxiu Wang; Susan R Ross
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 9.  Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way.

Authors:  Gelina S Kopeina; Evgeniia A Prokhorova; Inna N Lavrik; Boris Zhivotovsky
Journal:  Cell Prolif       Date:  2018-06-26       Impact factor: 6.831

10.  Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo.

Authors:  Leonid Gitlin; Loralyn Benoit; Christina Song; Marina Cella; Susan Gilfillan; Michael J Holtzman; Marco Colonna
Journal:  PLoS Pathog       Date:  2010-01-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.